Calls for UK to stock up on antibody Covid drug that slashes risk of illness by up to 80%

Evusheld, developed by AstraZeneca, could help people who did not get an immune response from the vaccine to return to normal life, campaigners claim. It was approved in Britain in March.Evusheld, developed by AstraZeneca, could help people who did not get an immune response from the vaccine to return to normal life, campaigners claim. It was approved in Britain in March.Read MoreHealth News | Mail Online